Trial Profile
EFFICACY OF AN EARLY ADMINISTRATION OF L0013CP 10 MG/DAY VERSUS PLACEBO DURING 4 WEEKS IN THE TREATMENT OF INFECTIOUS DISEASES INDUCED ARTHRITIS PAINFUL SYMPTOMS. A MULTICENTER, RANDOMISED, DOUBLE BLIND, PLACEBO CONTROLLED CLINICAL TRIAL IN ADULT PATIENTS SUFFERING FROM CHIKUNGUNYA FEVER.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 02 Jul 2012
Price :
$35
*
At a glance
- Drugs Mequitazine (Primary)
- Indications Arthritis
- Focus Therapeutic Use
- Sponsors Pierre Fabre
- 22 Jul 2011 New trial record